title: Regression of paclitaxel-induced maculopathy with oral acetazolamide.
authors: Kerstin Maria
authors: KM
authors: Meyer
authors: Thomas
authors: T
authors: Klink
authors: Selma
authors: S
authors: Ugurel
authors: Eva-Bettina
authors: EB
authors: Bröcker
mesh_terms: D000086:Acetazolamide / Q000627:therapeutic use*; D000284:Administration, Oral; D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002257:Carbonic Anhydrase Inhibitors / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008207:Lymphatic Metastasis; D008269:Macular Edema / Q000139:chemically induced / Q000188:drug therapy*; D008545:Melanoma / Q000188:drug therapy / Q000556:secondary; D008875:Middle Aged; D017239:Paclitaxel / Q000009:adverse effects*; D012878:Skin Neoplasms / Q000188:drug therapy / Q000473:pathology; D041623:Tomography, Optical Coherence; D014786:Vision Disorders / Q000139:chemically induced / Q000188:drug therapy*; D014792:Visual Acuity
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D002257:Carbonic Anhydrase Inhibitors; D000086:Acetazolamide; D017239:Paclitaxel